Publicacións en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (82)

2024

  1. PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy

    Drug Delivery and Translational Research

2023

  1. Bosques y orlas forestales de los territorios atlánticos del Noroeste Ibérico

    Guineana, Vol. 23, pp. 1-240

  2. H(N3)dap (Hdap = 2,6-Diaminopurine) Recognition by Cu2(EGTA): Structure, Physical Properties, and Density Functional Theory Calculations of [Cu4(μ-EGTA)2(μ-H(N3)dap)2(H2O)2]·7H2O

    Molecules, Vol. 28, Núm. 17

  3. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting

    Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8

2022

  1. Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function

    Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24

  2. Notas sobre el Catálogo de comunidades de plantas vasculares de los territorios iberoatlánticos (II)

    Naturalia Cantabricae, Núm. 10, pp. 29-60

  3. Proposal (30) to conserve the name Polysticho setiferi-Fraxinetum excelsioris (Tüxen et Oberdorfer 1958) Rivas-Martínez ex Díaz et Fernández Prieto 1994 with a conserved type

    Vegetation Classification and Survey, Vol. 3, pp. 187-189

  4. Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study

    Annals of medicine, Vol. 54, Núm. 1, pp. 379-392

  5. Synthesis of hybrid phosphorated indenoquinolines and biological evaluation as topoisomerase I inhibitors and antiproliferative agents

    Bioorganic and Medicinal Chemistry Letters, Vol. 57

  6. The design and discovery of topoisomerase I inhibitors as anticancer therapies

    Expert Opinion on Drug Discovery, Vol. 17, Núm. 6, pp. 581-601

2021

  1. A multicenter case–control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users

    Scientific Reports, Vol. 11, Núm. 1

  2. A patent review of topoisomerase I inhibitors (2016–present)

    Expert Opinion on Therapeutic Patents, Vol. 31, Núm. 6, pp. 473-508

  3. Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 222

  4. Design, synthesis and cytotoxic evaluation of diphenyl(quinolin-8-yl)phosphine oxides

    Tetrahedron Letters, Vol. 70

  5. Hybrid quinolinyl phosphonates as heterocyclic carboxylate isosteres: Synthesis and biological evaluation against topoisomerase 1b (top1b)

    Pharmaceuticals, Vol. 14, Núm. 8

  6. Simple and fast dna based sensor system for screening of small-molecule compounds targeting eukaryotic topoisomerase 1

    Pharmaceutics, Vol. 13, Núm. 8

  7. Synthesis, Pharmacological, and Biological Evaluation of 2-Furoyl-Based MIF-1 Peptidomimetics and the Development of a General-Purpose Model for Allosteric Modulators (ALLOPTML)

    ACS Chemical Neuroscience, Vol. 12, Núm. 1, pp. 203-215

  8. The L-α-Lysophosphatidylinositol/G Protein–Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis

    Hepatology, Vol. 73, Núm. 2, pp. 606-624

2020

  1. Aliarcobacter vitoriensis sp. nov., isolated from carrot and urban wastewater

    Systematic and Applied Microbiology, Vol. 43, Núm. 4

  2. Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease

    Journal of Medicinal Chemistry, Vol. 63, Núm. 7, pp. 3610-3633